Stockholm, Sweden
NCT Number: NCT00931294
Saliva Testosterone Increases in Irritable Bowel Syndrome (IBS) Patients Beginning Choir Singing
The hypothesis was that a one-year experience of choir singing once a week is more beneficial than group discussions to saliva concentration of testosterone.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
The project aimed to study the health effects of regular choir singing for persons who are in a psychosomatic condition (Irritable Bowel syndrome - IBS). A group of IBS patients were randomized to choir singing or an information group were followed during one year with biological and psychosocial assessments. The choir group participated in various relaxation, breathing and vocal exercises with the choir leader, and received the material "To live with IBS" for home studies. At the same time a comparison group with IBS patients meet in groups, studying and discussing on the same materials under the direction of a group leader. Both groups meet once per week.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- IBS according to physician certificates.
- Wish to start choir singing but no such experience during past ten years.
- Acceptance of randomisation condition.
Exclusion criteria
- No serious somatic diseases.
- No abuse of alcohol or drugs.
- No ongoing acute psychiatric condition.
Treatment and study plan
Choir singing
BehavioralChoir group participated in various relaxation, breathing and vocal exercises with the choir leader, and received the material "To Live with IBS" for home studies, weekly for 1 year. Saliva testosterone assessed 6 times per occasion; baseline, after 6, 9 and 12 months.
Information Group
BehavioralMeet in groups, studying and discussing on the same materials under the direction of a group leader, weekly, for 1 year. Saliva testosterone assessed 6 times per occasion; baseline, after 6, 9 and 12 months.
Primary outcomes
-
More reduction in bowel pain according to standardised international IBS questionnaire in choir group than in study group after one year.
Time frame: 1 year
Secondary outcomes
-
Significant increase in saliva testosterone concentration during study period in choir group.
Time frame: 1 year
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Stockholm University
Other
Collaborators
- Region Stockholm
- The Swedish Research Council
Registry information
Official study title
Saliva Testosterone Increases in Choir Singer Beginners: a Randomised Controlled Trial to Test the Efficacy of Choir Singing in Irritable Bowel Syndrome (IBS) Patients
Important dates
- Study start
- 2006
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Jul 2, 2009
- Registry last updated
- Jul 2, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
NCT03339128
Colonic Diseases, Colonic Diseases, Functional
Hot Springs, Arkansas, United States
View Trial DetailsShort-Term Effects of Low-FODMAP, NICE Dietary Advice, and Intermittent Fasting in Irritable Bowel Syndrome
NCT07829666
Behavior, Colonic Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsEvaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
NCT06271538
Colonic Disease, Colonic Diseases
Kubang Kerian, Kelantan, Malaysia
View Trial DetailsGI Alpha-Gal Study
NCT06268717
Abdominal Pain, Alpha-Gal Syndrome
Chapel Hill, North Carolina, United States
View Trial Details